このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Dermapharm Holding バランスシートの健全性
財務の健全性 基準チェック /36
Dermapharm Holdingの総株主資本は€587.2M 、総負債は€1.0Bで、負債比率は175.3%となります。総資産と総負債はそれぞれ€2.2Bと€1.6Bです。 Dermapharm Holdingの EBIT は€176.5Mで、利息カバレッジ比率4.3です。現金および短期投資は€117.4Mです。
主要情報
190.5%
負債資本比率
€1.06b
負債
| インタレスト・カバレッジ・レシオ | 3.7x |
| 現金 | €165.76m |
| エクイティ | €556.43m |
| 負債合計 | €1.65b |
| 総資産 | €2.21b |
財務の健全性に関する最新情報
These 4 Measures Indicate That Dermapharm Holding (ETR:DMP) Is Using Debt Extensively
Apr 29
Dermapharm Holding (ETR:DMP) Seems To Use Debt Quite Sensibly
Dec 15Dermapharm Holding (ETR:DMP) Has A Pretty Healthy Balance Sheet
Aug 28Dermapharm Holding (ETR:DMP) Has A Pretty Healthy Balance Sheet
May 29We Think Dermapharm Holding (ETR:DMP) Can Stay On Top Of Its Debt
Feb 22Is Dermapharm Holding (ETR:DMP) A Risky Investment?
Nov 17Recent updates
Dermapharm Holding SE Beat Revenue Forecasts By 6.7%: Here's What Analysts Are Forecasting Next
Aug 31Dermapharm Holding SE's (ETR:DMP) P/E Still Appears To Be Reasonable
Aug 17It Looks Like Dermapharm Holding SE's (ETR:DMP) CEO May Expect Their Salary To Be Put Under The Microscope
Jun 21These 4 Measures Indicate That Dermapharm Holding (ETR:DMP) Is Using Debt Extensively
Apr 29Dermapharm Holding SE's (ETR:DMP) Price In Tune With Earnings
Feb 07Dermapharm Holding (ETR:DMP) Seems To Use Debt Quite Sensibly
Dec 15An Intrinsic Calculation For Dermapharm Holding SE (ETR:DMP) Suggests It's 24% Undervalued
Nov 17Dermapharm Holding (ETR:DMP) Has A Pretty Healthy Balance Sheet
Aug 28Dermapharm Holding SE's (ETR:DMP) Intrinsic Value Is Potentially 76% Above Its Share Price
Aug 01Dermapharm Holding (ETR:DMP) Has A Pretty Healthy Balance Sheet
May 29Is Dermapharm Holding SE (ETR:DMP) Trading At A 44% Discount?
May 03Dermapharm Holding's (ETR:DMP) Soft Earnings Are Actually Better Than They Appear
Apr 04We Think Dermapharm Holding (ETR:DMP) Can Stay On Top Of Its Debt
Feb 22Is Dermapharm Holding (ETR:DMP) A Risky Investment?
Nov 17Is Dermapharm Holding (ETR:DMP) A Risky Investment?
Aug 16Is Dermapharm Holding (ETR:DMP) A Risky Investment?
May 18Is Dermapharm Holding (ETR:DMP) Using Too Much Debt?
Feb 17These 4 Measures Indicate That Dermapharm Holding (ETR:DMP) Is Using Debt Reasonably Well
Nov 19Does Dermapharm Holding (ETR:DMP) Have A Healthy Balance Sheet?
Aug 21Is Dermapharm Holding SE (ETR:DMP) Trading At A 28% Discount?
Jul 31Is Dermapharm Holding SE (ETR:DMP) The Right Choice For A Smart Dividend Investor?
May 03Calculating The Intrinsic Value Of Dermapharm Holding SE (ETR:DMP)
Apr 16Here's Why Dermapharm Holding (ETR:DMP) Can Manage Its Debt Responsibly
Mar 25Did You Miss Dermapharm Holding's (ETR:DMP) Impressive 110% Share Price Gain?
Mar 07Is Dermapharm Holding SE's (ETR:DMP) 27% ROE Better Than Average?
Feb 15Something To Consider Before Buying Dermapharm Holding SE (ETR:DMP) For The 1.4% Dividend
Jan 29Does Dermapharm Holding (ETR:DMP) Have A Healthy Balance Sheet?
Dec 24
The Dermapharm Holding (ETR:DMP) Share Price Has Gained 45% And Shareholders Are Hoping For More
Dec 07Dermapharm Holding SE Just Missed Earnings - But Analysts Have Updated Their Models
Nov 18財務状況分析
短期負債: DMPの 短期資産 ( €648.9M ) が 短期負債 ( €414.3M ) を超えています。
長期負債: DMPの短期資産 ( €648.9M ) は 長期負債 ( €1.2B ) をカバーしていません。
デット・ツー・エクイティの歴史と分析
負債レベル: DMPの 純負債対資本比率 ( 155.3% ) は 高い と見なされます。
負債の削減: DMPの負債対資本比率は、過去 5 年間で179.4%から175.3%に減少しました。
債務返済能力: DMPの負債は 営業キャッシュフロー によって 十分にカバーされていません ( 17.4% )。
インタレストカバレッジ: DMPの負債に対する 利息支払い は EBIT ( 4.3 x coverage) によって 十分にカバーされています。